GlassScriptPhysician profile
Ellen I Zanetakis
NPI 1942220702
$10,025.22
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,129 · 2020: $4,219 · 2021: $3,678.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,395.10 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,300.00 | 2020 | |
| Amgen INC. | $839.85 | 2019-2021 | |
| Abbvie INC. | $556.15 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $440.63 | 2020-2021 | |
| Lilly USA, LLC | $350.64 | 2019-2021 | |
| Genentech USA, INC. | $325.97 | 2019-2021 | |
| Ucb, INC. | $310.73 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $297.84 | 2019 | |
| Glaxosmithkline, LLC. | $246.45 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $246.29 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $136.52 | 2019-2020 | |
| Radius Health, INC. | $125.59 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $119.90 | 2019 | |
| Pfizer INC. | $108.75 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $94.52 | 2021 | |
| Celgene Corporation | $82.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.03 | 2019-2020 | |
| Horizon Therapeutics Plc | $12.96 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $4.86 | 2021 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Zanetakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.